159 related articles for article (PubMed ID: 32949964)
1. Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations.
Rojas S; Parravicini O; Vettorazzi M; Tosso R; Garro A; Gutiérrez L; Andújar S; Enriz R
Eur J Med Chem; 2020 Dec; 208():112792. PubMed ID: 32949964
[TBL] [Abstract][Full Text] [Related]
2. Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis.
Vettorazzi M; Menéndez C; Gutiérrez L; Andujar S; Appignanesi G; Enriz RD
J Comput Aided Mol Des; 2018 Jul; 32(7):781-791. PubMed ID: 29971548
[TBL] [Abstract][Full Text] [Related]
3. Probing the intermolecular interactions, binding affinity, charge density distribution and dynamics of silibinin in dual targets AChE and BACE1: QTAIM and molecular dynamics perspective.
Saravanan K; Sugarthi S; Suganya S; Kumaradhas P
J Biomol Struct Dyn; 2022; 40(23):12880-12894. PubMed ID: 34637680
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.
Tosso RD; Andujar SA; Gutierrez L; Angelina E; Rodríguez R; Nogueras M; Baldoni H; Suvire FD; Cobo J; Enriz RD
J Chem Inf Model; 2013 Aug; 53(8):2018-32. PubMed ID: 23834278
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the conformational space of the active site of D
Tosso RD; Zarycz MNC; Schiel A; Goicoechea Moro L; Baldoni HA; Angelina E; Enriz RD
J Comput Chem; 2022 Jul; 43(19):1298-1312. PubMed ID: 35638694
[TBL] [Abstract][Full Text] [Related]
6. New substituted aminopyrimidine derivatives as BACE1 inhibitors: in silico design, synthesis and biological assays.
Gutiérrez LJ; Parravicini O; Sánchez E; Rodríguez R; Cobo J; Enriz RD
J Biomol Struct Dyn; 2019 Jan; 37(1):229-246. PubMed ID: 29301478
[TBL] [Abstract][Full Text] [Related]
7. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity.
Angelina E; Andujar S; Moreno L; Garibotto F; Párraga J; Peruchena N; Cabedo N; Villecco M; Cortes D; Enriz RD
Mol Inform; 2015 Jan; 34(1):28-43. PubMed ID: 27490860
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor.
Parravicini O; Bogado ML; Rojas S; Angelina EL; Andujar SA; Gutierrez LJ; Cabedo N; Sanz MJ; López-Gresa MP; Cortes D; Enriz RD
J Mol Model; 2017 Sep; 23(9):273. PubMed ID: 28866777
[TBL] [Abstract][Full Text] [Related]
9. Conformational and electronic study of dopamine interacting with the D
Tosso RD; Parravicini O; Zarycz MNC; Angelina E; Vettorazzi M; Peruchena N; Andujar S; Enriz RD
J Comput Chem; 2020 Aug; 41(21):1898-1911. PubMed ID: 32511790
[TBL] [Abstract][Full Text] [Related]
10. Investigation of intermolecular interactions and stability of verubecestat in the active site of BACE1: Development of first model from QM/MM-based charge density and MD analysis.
Saravanan K; Sivanandam M; Hunday G; Mathiyalagan L; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2339-2354. PubMed ID: 30044206
[TBL] [Abstract][Full Text] [Related]
11. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
[TBL] [Abstract][Full Text] [Related]
12. Searching the "biologically relevant"conformation of dopamine: a computational approach.
Andujar SA; Tosso RD; Suvire FD; Angelina E; Peruchena N; Cabedo N; Cortes D; Enriz RD
J Chem Inf Model; 2012 Jan; 52(1):99-112. PubMed ID: 22146008
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydroisoquinolines acting as dopaminergic ligands. A molecular modeling study using MD simulations and QM calculations.
Andujar S; Suvire F; Berenguer I; Cabedo N; Marín P; Moreno L; Dolores Ivorra M; Cortes D; Enriz RD
J Mol Model; 2012 Feb; 18(2):419-31. PubMed ID: 21523539
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
15. An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.
Vettorazzi M; Angelina E; Lima S; Gonec T; Otevrel J; Marvanova P; Padrtova T; Mokry P; Bobal P; Acosta LM; Palma A; Cobo J; Bobalova J; Csollei J; Malik I; Alvarez S; Spiegel S; Jampilek J; Enriz RD
Eur J Med Chem; 2017 Oct; 139():461-481. PubMed ID: 28822281
[TBL] [Abstract][Full Text] [Related]
16. Binding Analysis of Some Classical Acetylcholinesterase Inhibitors: Insights for a Rational Design Using Free Energy Perturbation Method Calculations with QM/MM MD Simulations.
Nascimento ÉCM; Oliva M; Świderek K; Martins JBL; Andrés J
J Chem Inf Model; 2017 Apr; 57(4):958-976. PubMed ID: 28406297
[TBL] [Abstract][Full Text] [Related]
17. Exploring PfDHFR reaction surface: A combined molecular dynamics and QM/MM analysis.
Abbat S; Jaladanki CK; Bharatam PV
J Mol Graph Model; 2019 Mar; 87():76-88. PubMed ID: 30508692
[TBL] [Abstract][Full Text] [Related]
18. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.
Rastelli G; Del Rio A; Degliesposti G; Sgobba M
J Comput Chem; 2010 Mar; 31(4):797-810. PubMed ID: 19569205
[TBL] [Abstract][Full Text] [Related]
19. Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.
Vettorazzi M; Díaz I; Angelina E; Salido S; Gutierrez L; Alvarez SE; Cobo J; Enriz RD
Bioorg Chem; 2024 Mar; 144():107112. PubMed ID: 38237390
[TBL] [Abstract][Full Text] [Related]
20. In Silico Prediction of Ligand Binding Energies in Multiple Therapeutic Targets and Diverse Ligand Sets-A Case Study on BACE1, TYK2, HSP90, and PERK Proteins.
Frush EH; Sekharan S; Keinan S
J Phys Chem B; 2017 Aug; 121(34):8142-8148. PubMed ID: 28759991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
